Education
About Us
Working with TipRanks
Follow Us
Insulet (PODD)
NASDAQ:PODD
PODD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$173.00 - $329.33
Previous CloseN/A
Volume86.50K
Average Volume (3M)746.70K
Market Cap
$20.29B
Enterprise Value$19.21B
Total Cash (Recent Filing)$1.28B
Total Debt (Recent Filing)$83.10M
Price to Earnings (P/E)51.0
Beta1.10
Next Earnings
Aug 07, 2025EPS Estimate
0.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.02
Shares Outstanding70,374,920
10 Day Avg. Volume477,139
30 Day Avg. Volume746,704
Financial Highlights & Ratios
PEG Ratio-12.81
Price to Book (P/B)15.36
Price to Sales (P/S)0.00
P/FCF Ratio70.35
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue2.36
Enterprise Value/Gross Profit12.41
Enterprise Value/Ebitda11.40
Forecast
1Y Price Target
$340.84Price Target Upside19.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
Insulet News
Bulls Say, Bears Say
Bulls Say
Financial PerformancePODD raised its worldwide Omnipod constant currency sales growth guidance to 20-23%, up from a previous range of 17-21%.
Innovation And GrowthInsulet is experiencing robust growth from the Type 2 launch, at an early stage in the adoption curve.
Market PositionPODD is recognized as a market leader in the pump market, bolstered by sensor integrations and entry into new markets.
Bears Say
Competitive EnvironmentPODD's premium trading price may reflect challenges in maintaining its competitive edge and high growth rate.
Ownership Overview
0.37% Insiders
43.32% Mutual Funds
1.15% Other Institutional Investors
28.40% Public Companies and Individual Investors
PODD FAQ
What was Insulet’s price range in the past 12 months?
Insulet lowest stock price was $173.00 and its highest was $329.33 in the past 12 months.
What is Insulet’s market cap?
Insulet’s market cap is $20.29B.
When is Insulet’s upcoming earnings report date?
Insulet’s upcoming earnings report date is Aug 07, 2025 which is in 19 days.
How were Insulet’s earnings last quarter?
Insulet released its earnings results on May 08, 2025. The company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.23.
Is Insulet overvalued?
According to Wall Street analysts Insulet’s price is currently Undervalued.
Does Insulet pay dividends?
Insulet does not currently pay dividends.
What is Insulet’s EPS estimate?
Insulet’s EPS estimate is 0.92.
How many shares outstanding does Insulet have?
Insulet has 70,374,920 shares outstanding.
What happened to Insulet’s price movement after its last earnings report?
Insulet reported an EPS of $1.02 in its last earnings report, beating expectations of $0.79. Following the earnings report the stock price went up 20.883%.
Which hedge fund is a major shareholder of Insulet?
Currently, no hedge funds are holding shares in PODD
Insulet Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$340.84 (19.92% Upside)
$340.84 (19.92% Upside)
Blogger Sentiment
Bullish
PODD Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 571.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 3.4%
Last 30 Days ▼ 3.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.41%
12-Months-Change
Fundamentals
Return on Equity
37.92%
Trailing 12-Months
Asset Growth
34.04%
Trailing 12-Months
Company Description
Insulet
Insulet Corporation (PODD) is a medical device company that primarily operates in the healthcare sector, specializing in innovative insulin delivery systems. The company's flagship product is the Omnipod Insulin Management System, a tubeless insulin pump that provides a continuous supply of insulin to individuals with diabetes. Insulet's products are designed to improve the quality of life for diabetes patients by simplifying insulin delivery and reducing the burden of traditional insulin management methods.
PODD Company Deck
PODD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance with significant revenue and gross margin growth. The company's expansion into the type 2 diabetes market and international markets is progressing well. While there are some challenges related to tariffs and increased interest expenses, these are being effectively managed. Overall, the company's positive achievements and strategic growth plans outweigh the lowlights.Read More>PODD Revenue Breakdown
74.73% U.S.
25.27% International
PODD Stock 12 Month Forecast
Average Price Target
$340.84
▲(19.92%Upside)